BioSpace News Archive

Vaxxinity, Inc. (“Vaxxinity”), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced the pricing of its initial public offering of 6,000,000 shares of class A common stock at a public offering price of $13.00 per share.

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced it plans to support a Phase 2/3 study to evaluate lenzilumab for the early treatment of acute graft versus host disease (aGvHD).

The molecular biology enzymes, kits, and reagents market has been predicted to grow at a significant speed in the incoming years.

Transparency Market Research has published a new report titled, “Medical Aesthetic Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

The epilepsy monitoring devices market has been estimated to grow at a significant speed in the forthcoming years.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the latest study published by Fact.MR, the global medical beds market is projected to surpass US$ 3.8 Bn in 2021.